- secretometherapeutics.com
- 21
Adult stem cells exhibit significant variability from person to person, making it difficult to achieve the consistency required by the U.S. FDA for drug development. Our lead drug, STM-01, and its secretome, STM-21, are derived from neonatal sources..
Relevance: 37.642616